2Parkinson J. An essay on the shaking palsy[ J]. J Neuropsychiatry Clin Neurosci, 2002, 14(2) : 223 -236.
3Pal PK, Thennarasu K, Fleming J, et al. Nocturnal sleep disturbances and daytime dysfunction in patients with parkinson's disease and in their caregivers [ J]. Parkinsonism Relat Disord, 2004, 10 (3) : 157 - 168.
4Mehta SH, Morgan JC, Sethi KD. Sleep disorders associated with Parkinson's disease: role of dopamine, epidemiology, and clinical scales of assessment[J]. CNS Spectr, 2008, 13(3 Suppl 4) : 6 -11.
5Dhawan V, Healy DG, Pal S, et al. Sleep-related problems of Parkinson's disease[ J]. Age Ageing, 2006, 35 (3) : 220 - 228.
6Saper CB, Chou TC, Seammell TE. The sleep switch : the hypothalamic control of sleep and wakefulness[ J]. Trends Neurosci, 2001, 24(12) : 726 -731.
7Ripley B, Overeem S, Fujiki N, et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions [ J ]. Neurology, 2001, 57( 12): 2253-2258.
8Monaca C, Laloux C, Jacquesson JM, et al. Vigilance states in a parkinsonian model, the MPTP mouse[ J]. Eur J Neurosci, 2004, 20(9) : 2474 -2478.
9Clemens S, Rye DB, Hochman S. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective [ J ]. Neurology, 2006, 67 ( 1 ) : 125 - 130.
10Cavas M, Navarro JF. Effects of selective dopamine 134 receptor antagonist, L-741, 741, on sleep and wakefulness in the rat[J]. Prog Neuropsyehopharmacol Biol Psychiatry, 2006, 30 (4) : 668 - 678.
